Healthcare > Medical Devices & Equipment
•437 stocks
•
Total Market Cap: Loading...
Market Cap Distribution
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (437)
%
| Company | Market Cap | Price |
|---|---|---|
|
Cardiology devices and related therapies (e.g., Impella pumps, IVL) form a core MedTech growth area.
|
$458.89B |
$190.72
-0.67%
|
|
Oral-B iO toothbrush is a dental equipment product PG directly sells.
|
$350.95B |
$149.69
-0.82%
|
|
Abbott directly manufactures diagnostic equipment and systems (e.g., Alinity N, transfusion diagnostics) as a core business.
|
$230.52B |
$132.57
-1.21%
|
|
Thermo Fisher manufactures diagnostic equipment and analytical instruments (e.g., mass spectrometers, Cryo-EM, lab automation).
|
$198.11B |
$524.80
-1.88%
|
|
Intuitive Surgical's core business is the design, manufacture, and sale of da Vinci surgical robotic systems and associated instruments, i.e., surgical equipment.
|
$153.97B |
$429.59
-3.26%
|
|
Diagnostic Equipment encompasses instruments like DxC 500i, DXi 9000, and Cepheid platforms used in clinical diagnostics.
|
$144.89B |
$202.46
-1.20%
|
|
Directly manufactures and markets cardiovascular medical devices, including WATCHMAN LAAC and AF ablation products (FARAPULSE).
|
$141.15B |
$95.41
-1.94%
|
|
Orthopedic Devices - core product category including implants and joint replacement systems (e.g., hips, knees, trauma implants).
|
$139.34B |
$364.60
-1.54%
|
|
Diagnostic Equipment – KLAC's tools function as diagnostic instruments for yield management and defect characterization in semiconductor manufacturing.
|
$129.96B |
$982.75
-6.61%
|
|
Medtronic's core Cardiology Devices portfolio includes leadless pacemakers, ablation catheters, and structural heart implants (e.g., TAVR), driving its largest revenue and growth in cardiovascular care.
|
$122.30B |
$95.45
-1.27%
|
|
Vital Signs Monitoring platform and health wearables-related sensing capabilities for patient monitoring.
|
$111.81B |
$225.32
-5.22%
|
|
Healthcare delivery assets (Signify Health, Oak Street Health) underpin hospital‑like services and at‑home care.
|
$98.55B |
$77.90
-0.33%
|
|
Medical Device Consumables are disposable items sold/distributed for use with medical devices, a service McKesson provides through its Medical-Surgical Solutions.
|
$95.72B |
$765.08
-0.68%
|
|
Diagnostic Equipment reflects ITW's Test & Measurement focus within electronics/testing domains.
|
$71.76B |
$244.93
-1.60%
|
|
Zoetis offers diagnostic equipment for veterinary medicine.
|
$62.82B |
$141.11
-1.59%
|
|
Verathon’s video laryngoscope and related surgical devices place the company in surgical equipment.
|
$54.73B |
$509.00
-2.25%
|
|
BD markets diagnostic instruments and platforms (e.g., Onclarity HPV assay, FACSDiscover) directly enabling disease detection and analysis.
|
$53.47B |
$186.56
-1.50%
|
|
IDEXX directly manufactures diagnostic equipment (in-clinic analyzers and related systems) used for veterinary diagnostics, a core product line.
|
$49.55B |
$616.15
-2.00%
|
|
Prefillable Syringes indicating self-injection delivery formats for antibody therapies.
|
$47.65B |
$796.92
-0.76%
|
|
Edwards Lifesciences' core offerings are cardiology devices, including transcatheter heart valves and other structural heart therapies.
|
$43.37B |
$73.94
-1.58%
|
|
Agilent's core offering is analytical instruments and diagnostic equipment (GC/GCMS, LC/LCMS) used in life sciences, diagnostics, and applied markets.
|
$40.00B |
$140.11
-0.12%
|
|
NightOwl and at-home sleep apnea diagnostic capabilities constitute Diagnostic Equipment offerings.
|
$39.88B |
$272.00
-2.10%
|
|
At-Home Solutions and its home-based patient monitoring capabilities align with the Patient Monitoring category (home health devices and services).
|
$37.44B |
$156.88
-0.61%
|
|
Alcon directly designs, manufactures, and sells ophthalmology devices including Unity VCS, PanOptix Pro IOL, Voyager DSLT, Clareon-based IOLs, LumiThera Valeda system, and STAAR EVO ICLs.
|
$35.64B |
$72.05
-3.44%
|
|
GE HealthCare manufactures and sells Medical Imaging devices (CT, MR, ultrasound) as core product lines.
|
$32.51B |
$71.01
-4.05%
|
|
Philips' primary product line includes medical imaging hardware and imaging modalities (MRI, CT, ultrasound) used for diagnostics.
|
$26.88B |
$27.35
|
|
MTD directly manufactures imaging, laboratory and point-of-care diagnostic instruments (diagnostic equipment).
|
$26.47B |
$1273.67
-2.72%
|
|
DexCom's CGM devices are patient monitoring devices providing real-time glucose data.
|
$25.53B |
$65.12
-4.45%
|
|
Veralto directly provides diagnostic equipment and instrumentation for water analysis (e.g., Hach).
|
$25.25B |
$101.87
-0.97%
|
|
STERIS offers medical device consumables such as detergents and sterility assurance products tied to its infection-prevention offerings.
|
$23.84B |
$239.42
-1.77%
|
|
Labcorp leverages medical imaging capabilities (digital pathology) and imaging software internally to support diagnostics.
|
$23.26B |
$277.88
-0.11%
|
|
Signatera and related cfDNA tests operate as liquid biopsy diagnostic tests detecting circulating tumor DNA.
|
$22.07B |
$161.61
+0.94%
|
|
Waterpik water flossers and dental devices purchased/sold by CHD align with Dental Equipment.
|
$21.60B |
$87.70
-0.17%
|
|
The system relies on CGM data for insulin delivery, reflecting Patient Monitoring capabilities.
|
$21.53B |
$305.98
-0.90%
|
|
Medical Device Components covers manufacturing of components for medical devices (e.g., autoinjectors) arising from healthcare-focused capabilities.
|
$20.82B |
$193.99
-5.75%
|
|
Quest Diagnostics offers liquid biopsy diagnostic tests (e.g., Haystack MRD) and other circulating biomarker-based assays, a major liquid biopsy product category.
|
$20.55B |
$184.07
+0.97%
|
|
Medical Device Consumables capture ongoing revenue from drug-delivery devices and associated accessories (e.g., Remunity/ Tyvaso delivery systems).
|
$19.85B |
$440.00
-1.27%
|
|
Zimmer Biomet's core business is orthopedic implants and devices (hips, knees) and related orthopedic products.
|
$19.84B |
$99.20
-1.08%
|
|
Waters manufactures and sells diagnostic equipment (analytical instruments such as LC/UPLC and MS systems) used in regulated laboratory testing.
|
$19.70B |
$331.00
+0.16%
|
|
West's GLP-1 self-injection device platforms (Auto-Injector Devices) are a core product line.
|
$18.81B |
$261.77
-1.19%
|
|
Tenet provides hospital services, including inpatient and outpatient hospital operations.
|
$17.61B |
$189.58
-2.87%
|
|
BWXT's strategy includes Laboratory Testing & Advisory Services via Kinectrics integration for testing and regulatory support.
|
$17.37B |
$190.08
-2.82%
|
|
RS&I provides diagnostic equipment and repair information platforms used by professional technicians.
|
$17.12B |
$327.33
-1.72%
|
|
Primary business includes Laboratory Testing & Advisory Services, including genomics and hereditary testing via Ambry Genetics.
|
$16.69B |
$96.39
-4.47%
|
|
Fluke and other Fortive instrumentation are diagnostic/testing equipment sold to customers.
|
$16.25B |
$47.80
-3.45%
|
|
Core product category including dialysis devices and dialyzers used for blood purification in renal therapy.
|
$15.80B |
$53.85
|
|
Directly produces blood purification devices (dialysis machines) and related dialysis equipment.
|
$15.74B |
$26.82
-1.76%
|
|
Core product category including joint implants (hip/knee) and related orthopedic devices.
|
$15.42B |
$17.71
|
|
Illumina directly manufactures sequencing instruments (e.g., NovaSeq X, MiSeq i100 Plus), which are diagnostic equipment.
|
$14.86B |
$93.86
-2.73%
|
|
Hologic's Panther Fusion and other diagnostic instruments place it in the Diagnostic Equipment category.
|
$14.78B |
$67.92
+0.94%
|
|
Directly provides Laboratory Testing & Advisory Services (TIC) and related testing/advisory work.
|
$14.47B |
$72.16
-1.57%
|
|
Medpace offers bio-analytical laboratory services and regulatory advisory as part of its CRO offerings.
|
$14.41B |
$501.22
-3.28%
|
|
CooperVision eye-care products (daily silicone hydrogel lenses, MiSight, etc.) are ophthalmology devices sold as eye-care medical devices.
|
$14.02B |
$69.75
-0.53%
|
|
Dental Equipment is a primary product category for Solventum's Dental Solutions segment, including 3D-printed components like attachments.
|
$12.91B |
$74.29
-0.42%
|
|
The company offers Laboratory Testing & Advisory Services, including PFAS testing validated with regulatory agencies, aligning with PFAS remediation and environmental testing capabilities.
|
$12.53B |
$233.95
+0.58%
|
|
Owns/operates lab testing facility Trybe Labs enabling diagnostics and data for treatment customization.
|
$12.08B |
$53.95
-7.45%
|
|
Baxter's product portfolio includes surgical equipment and devices (e.g., Hemopatch sealing hemostat) used in operating rooms.
|
$11.26B |
$21.95
-3.09%
|
|
EXAS directly develops and sells diagnostic tests and related laboratory testing services for cancer screening and oncology diagnostics.
|
$11.01B |
$58.34
-2.11%
|
|
QIAGEN sells diagnostic equipment and platforms (QIAstat-Dx, QIAcuity, and automation systems).
|
$10.49B |
$46.85
-1.10%
|
|
Penumbra's core products are endovascular vascular intervention devices (thrombectomy systems, catheters, and embolization coils).
|
$10.09B |
$260.49
+0.14%
|
|
Ensign delivers post-acute healthcare services including skilled nursing, senior living, and rehabilitative care, aligning with hospital/healthcare services themes.
|
$10.08B |
$175.34
-0.59%
|
|
Diagnostics-related products/services including diagnostic instruments and software.
|
$9.91B |
$84.06
+0.79%
|
|
Remote patient monitoring via connected dialysis cyclers is part of care delivery.
|
$9.36B |
$123.99
-2.28%
|
|
Align directly designs and sells dental devices (Invisalign aligners, mandibular advancement tools, palate expanders) which fall under the Dental Equipment category.
|
$9.12B |
$125.79
-2.26%
|
|
Nova sells diagnostic/measurement instruments as part of its metrology platforms.
|
$8.80B |
$302.28
-6.22%
|
|
Bio-Techne's automated diagnostic platforms and instruments (e.g., COMET, Simple Western) are core offerings sold under Diagnostic Equipment.
|
$8.72B |
$55.63
+6.51%
|
|
Activates capability in Medical Device Components design and manufacturing (e.g., components for drug-delivery devices).
|
$8.65B |
$130.93
-0.01%
|
|
Bio-Rad develops and markets diagnostic instruments and platforms, including PCR-based systems used in diagnostics.
|
$8.10B |
$284.88
|
|
Core product category: Liquid biopsy testing platform used for cancer detection, MRD monitoring, and early screening.
|
$7.96B |
$64.22
-3.53%
|
|
Halozyme is developing and commercializing auto-injector technologies to support at-home administration of injectable therapies.
|
$7.90B |
$64.10
-2.20%
|
|
Masimo's core offerings are noninvasive patient monitoring devices and systems, which define its main revenue through ongoing monitoring solutions.
|
$7.84B |
$144.64
-4.29%
|
|
Bio-Rad markets diagnostic instruments and related equipment used in clinical labs and research settings.
|
$7.73B |
$284.07
-0.50%
|
|
Directly manufactures or distributes dental equipment and related products used in dental practices.
|
$7.69B |
$63.17
-2.35%
|
|
Orthopedic devices portfolio including spine implants, trauma hardware, and joint systems.
|
$7.66B |
$56.57
-5.32%
|
|
The company produces safety syringes as part of its high-value syringe offerings.
|
$7.22B |
$23.85
-0.58%
|
|
MSA markets and sells diagnostic equipment, including gas detectors and related monitoring devices.
|
$6.70B |
$170.57
-0.17%
|
|
The company’s diagnostics platform and related equipment/reagents position it in the diagnostic equipment space.
|
$6.41B |
$9.32
-1.58%
|
|
VITAS Hospice provides hospital-style healthcare services (palliative/hospice care), aligning with the Hospital Services investable theme.
|
$6.29B |
$430.02
-0.50%
|
|
New healthcare/biometrics platform via recent acquisitions (medical devices and iris biometrics).
|
$5.76B |
$25.63
-2.47%
|
|
Core product is a patch-based cardiac monitoring device (Cardiology Devices).
|
$5.63B |
$176.20
-1.06%
|
|
Doble diagnostic testing instruments align with ESCO's USG segment's diagnostic equipment offerings.
|
$5.45B |
$210.07
-0.42%
|
|
Mirion manufactures diagnostic equipment including radiation detection and measurement devices.
|
$5.36B |
$23.12
-1.53%
|
|
Bruker sells diagnostic-grade instrumentation and analytical systems used in clinical/research diagnostics.
|
$5.35B |
$35.28
-2.54%
|
|
RadNet's core business is outpatient diagnostic imaging services across MRI, CT, PET, mammography, and ultrasound, i.e., medical imaging services.
|
$5.30B |
$70.60
-3.30%
|
|
Titan SGS stapler and Barrigel rectal spacer are clearly surgical devices used in operating rooms or procedural settings.
|
$5.28B |
$119.42
-4.53%
|
|
The company's enVista, LuxLife, and Beyond intraocular lenses and other eye-care implants are ophthalmology devices.
|
$5.06B |
$14.32
-1.45%
|
|
Glaukos directly designs, manufactures, and markets ophthalmology devices, including MIGS implants like the iStent infinite.
|
$4.72B |
$82.56
-5.10%
|
|
Produces diagnostic and measurement equipment used in laboratory and industrial settings as part of its precision instrumentation portfolio.
|
$4.71B |
$41.42
-5.11%
|
|
Wrappersody vascular endoprosthesis and related vascular intervention devices are core Merit Medical products.
|
$4.67B |
$78.99
-3.99%
|
|
AMI provides compositional analysis instrumentation, aligning with diagnostic equipment in analytical instrumentation.
|
$4.53B |
$215.12
-2.93%
|
|
Nelson Labs provides outsourced laboratory testing and advisory services, a core service line.
|
$4.36B |
$15.35
-2.66%
|
|
Healthcare division includes patient monitoring platforms and related devices/services.
|
$3.98B |
$236.79
-0.53%
|
|
Lantheus markets imaging agents used in PET and ultrasound (e.g., PYLARIFY and DEFINITY), a core medical imaging product line.
|
$3.68B |
$53.23
+2.54%
|
|
OCS provides real-time patient/organ monitoring data during ex vivo perfusion.
|
$3.63B |
$107.29
-5.50%
|
|
Healthcare/Life Sciences supports medical device components manufacturing and subassemblies.
|
$3.62B |
$133.69
-9.20%
|
|
Next-generation insufflators and endoscopic pumps indicate direct medical-surgical equipment offerings.
|
$3.60B |
$99.96
-5.25%
|
|
Provides medical device components and subsystems as a core manufacturing capability.
|
$3.53B |
$101.05
-1.93%
|
|
Laboratory Testing & Advisory Services: provision of genetic diagnostic tests and related advisory services.
|
$3.47B |
$121.72
-4.53%
|
|
Laser-based medical devices used in surgical/medical settings position IPG within Surgical Equipment.
|
$3.43B |
$80.68
-7.23%
|
|
Illuccix/Gozellix represent radiopharmaceutical imaging agents used for PET/diagnostic imaging, aligning with Medical Imaging.
|
$3.35B |
$10.00
|
Showing page 1 of 5 (437 total stocks)
Loading industry metrics...
Loading comparison data...
